Zobrazeno 1 - 10
of 249
pro vyhledávání: '"Owen A"'
Autor:
Owen, Natalia E.1 (AUTHOR) neo25@cam.ac.uk, Barker, Roger A.1,2 (AUTHOR), Voysey, Zanna J.1 (AUTHOR)
Publikováno v:
Journal of Huntington's Disease. 2023, Vol. 12 Issue 2, p149-161. 13p.
More efficient use of household consumption and expenditure surveys (HCES) to inform food security1.
Autor:
Mathiassen, Astrid1 (AUTHOR) astrid.mathiassen@ssb.no, Siyoto, Owen2 (AUTHOR), Kiøsterud, Ellen Cathrine1 (AUTHOR)
Publikováno v:
Statistical Journal of the IAOS. 2024, Vol. 40 Issue 2, p269-278. 10p.
More efficient use of household consumption and expenditure surveys (HCES) to inform food security1.
Publikováno v:
Statistical Journal of the IAOS; 2024, Vol. 40 Issue 2, p269-278, 10p
More efficient use of household consumption and expenditure surveys (HCES) to inform food security1.
Autor:
Mathiassen, Astrid1 (AUTHOR) astrid.mathiassen@ssb.no, Siyoto, Owen2 (AUTHOR), Kiøsterud, Ellen Cathrine1 (AUTHOR)
Publikováno v:
Statistical Journal of the IAOS. 2024, Vol. 40 Issue 2, p269-278. 10p.
Publikováno v:
Journal of Huntington's Disease. :1-13
Sleep dysfunction is highly prevalent in Huntington’s disease (HD). Increasing evidence suggests that such dysfunction not only impairs quality of life and exacerbates symptoms but may even accelerate the underlying disease process. Despite this, c
Autor:
Ileana De Anda-Duran, Vijaya B. Kolachalama, Owen T. Carmichael, Phillip H. Hwang, Camilo Fernandez, Rhoda Au, Lydia A. Bazzano, David J. Libon
Publikováno v:
Journal of Alzheimer's Disease. :1-13
Background: Individuals with Alzheimer’s disease (AD) often present with coexisting vascular pathology that is expressed to different degrees and can lead to clinical heterogeneity. Objective: To examine the utility of unsupervised statistical clus
Autor:
Owen Davis Sanders
Publikováno v:
Journal of Alzheimer's Disease Reports. 7:1-19
Oxidative stress, inflammation, and amyloid-β are Alzheimer’s disease (AD) hallmarks that cause each other and other AD hallmarks. Most amyloid-β-lowering, antioxidant, anti-inflammatory, and antimicrobial AD clinical trials failed; none stopped
Autor:
Rodrigues, Filipe B.1 (AUTHOR), Owen, Gail1 (AUTHOR), Sathe, Swati2 (AUTHOR), Pak, Elena2 (AUTHOR), Kaur, Dipinder2 (AUTHOR), Ehrhardt, Anka G.2 (AUTHOR), Lifer, Sherry2 (AUTHOR), Townhill, Jenny3 (AUTHOR), Schubert, Katarzyna1 (AUTHOR), Leavitt, Blair R.4 (AUTHOR), Guttman, Mark5 (AUTHOR), Bang, Jee6 (AUTHOR), Lewerenz, Jan7 (AUTHOR), Levey, Jamie2,3 (AUTHOR), Sampaio, Cristina2 (AUTHOR), Wild, Edward J.1 (AUTHOR) e.wild@ucl.ac.uk
Publikováno v:
Journal of Huntington's Disease. 2022, Vol. 11 Issue 1, p59-69. 11p.
Publikováno v:
Journal of Computer Security; 2023, Vol. 31 Issue 5, p615-645, 31p
Autor:
Filipe B, Rodrigues, Gail, Owen, Swati, Sathe, Elena, Pak, Dipinder, Kaur, Anka G, Ehrhardt, Sherry, Lifer, Jenny, Townhill, Katarzyna, Schubert, Blair R, Leavitt, Mark, Guttman, Jee, Bang, Jan, Lewerenz, Jamie, Levey, Cristina, Sampaio, Edward J, Wild
Publikováno v:
Journal of Huntington's Disease. 11:59-69
Background: Biomarkers are needed to monitor disease progression, target engagement and efficacy in Huntington’s disease (HD). Cerebrospinal fluid (CSF) is an ideal medium to research such biomarkers due to its proximity to the brain. Objective: To